SS, D., HM, F., A, D., CM, O., KC, B., I, Y., & T, E. (2026). Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia. JAMA network open, 9(2), e2557536. https://doi.org/10.1001/jamanetworkopen.2025.57536
Chicago Style (17th ed.) CitationSS, Downen, Farag HM, Davies A, Okeke CM, Ben-Umeh KC, Yunusa I, and Eguale T. "Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran Vs Amitriptyline for Moderate to Severe Fibromyalgia." JAMA Network Open 9, no. 2 (2026): e2557536. https://doi.org/10.1001/jamanetworkopen.2025.57536.
MLA (9th ed.) CitationSS, Downen, et al. "Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran Vs Amitriptyline for Moderate to Severe Fibromyalgia." JAMA Network Open, vol. 9, no. 2, 2026, p. e2557536, https://doi.org/10.1001/jamanetworkopen.2025.57536.